Keros Therapeutics, Inc. (KROS) Market Cap
- 2026-09-03: Market Cap $220.28M.
- 2026-07-27: Market Cap $202.44M.
- 2026-06-30: Market Cap $212.15M.
- 2026-05-08: Market Cap $238.89M.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2020-05-15 to 2026-09-03
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|
| 2026-09-03 | $220.28M |
|---|
| 2026-07-27 | $202.44M |
|---|
| 2026-06-30 | $212.15M |
|---|
| 2026-05-08 | $238.89M |
|---|
| 2026-03-31 | $217.85M |
|---|
| 2026-02-27 | $279.79M |
|---|
| 2025-12-31 | $397.91M |
|---|
| 2025-10-31 | $463.69M |
|---|
| 2025-09-30 | $642.8M |
|---|
| 2025-07-31 | $581.61M |
|---|
| 2025-06-30 | $542.22M |
|---|
| 2025-05-01 | $591.77M |
|---|
| 2025-03-31 | $413.33M |
|---|
| 2025-02-20 | $447.4M |
|---|
| 2024-12-31 | $641.98M |
|---|
| 2024-10-31 | $2.35B |
|---|
| 2024-09-30 | $2.28B |
|---|
| 2024-07-31 | $1.88B |
|---|
| 2024-06-30 | $1.65B |
|---|
| 2024-05-01 | $2.08B |
|---|
| 2024-03-31 | $2.39B |
|---|
| 2024-02-21 | $2.15B |
|---|
| 2023-12-31 | $1.27B |
|---|
| 2023-10-31 | $855.04M |
|---|
| 2023-09-30 | $946.17M |
|---|
| 2023-07-28 | $1.24B |
|---|
| 2023-06-30 | $1.19B |
|---|
| 2023-04-27 | $1.3B |
|---|
| 2023-03-31 | $1.26B |
|---|
| 2023-02-23 | $1.54B |
|---|
| 2022-12-31 | $1.32B |
|---|
| 2022-10-27 | $1.32B |
|---|
| 2022-09-30 | $981.02M |
|---|
| 2022-07-29 | $826.28M |
|---|
| 2022-06-30 | $674.98M |
|---|
| 2022-04-29 | $1.27B |
|---|
| 2022-03-31 | $1.31B |
|---|
| 2022-03-02 | $1.25B |
|---|
| 2021-12-31 | $1.4B |
|---|
| 2021-10-28 | $987.89M |
|---|
| 2021-09-30 | $925.58M |
|---|
| 2021-07-27 | $854.17M |
|---|
| 2021-06-30 | $990.77M |
|---|
| 2021-04-29 | $1.63B |
|---|
| 2021-03-31 | $1.43B |
|---|
| 2021-03-19 | $1.38B |
|---|
| 2020-12-31 | $1.64B |
|---|
| 2020-11-03 | $1.07B |
|---|
| 2020-09-30 | $778.56M |
|---|
| 2020-08-07 | $732.26M |
|---|
| 2020-06-30 | $756.13M |
|---|
| 2020-05-15 | $576.25M |
|---|